Skip to main navigation Skip to search Skip to main content

Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

  • Takeshi Arashiro
  • , Yuzo Arima
  • , Jin Kuramochi
  • , Hirokazu Muraoka
  • , Akihiro Sato
  • , Kumi Chubachi
  • , Atsushi Yanai
  • , Hiroko Arioka
  • , Yuki Uehara
  • , Genei Ihara
  • , Yasuyuki Kato
  • , Naoki Yanagisawa
  • , Akihiro Ueda
  • , Hideaki Kato
  • , Hideaki Oka
  • , Yusuke Nishida
  • , Yuki Nidaira
  • , Takahiro Asami
  • , Torahiko Jinta
  • , Akira Nakamura
    • Kunihiro Oba, Daisuke Taniyama, Kei Yamamoto, Katsushi Tanaka, Kankuro Ueshima, Tetsuji Fuwa, Ashley Stucky, Tadaki Suzuki, Chris Smith, Martin Hibberd, Koya Ariyoshi, Motoi Suzuki

Research output: Contribution to journal › Article › peer-review

15   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Veterinary Science and Veterinary Medicine